DISCRIMINATION OF (+)-3-PPP SITES FROM DTG SITES BY FH-510, A NOVEL POTENT SIGMA-LIGAND, IN RAT-BRAIN

被引:2
作者
CHAKI, S
TANAKA, M
MURAMATSU, M
OTOMO, S
机构
[1] Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd., Saitama, 330, 1-403 Yoshino-cho, Ohmiya
关键词
SIGMA-BINDING SITE; FH-510 (5,8-DIMETHYL-4-(2-DI-N-PROPYLAMINOETHYL)CARBAZOL); (+)-3-PPP ((+)-3-(3-HYDROXYPHENYL)-N-(1-PROPYL)PIPERIDINE); DTG (1,3-DI-O-TOLYLGUANIDINE);
D O I
10.1016/0014-2999(93)90638-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of 5,8-dimethyl-4-(2-di-n-propylaminoethyl)carbazol monohydrochloride (FH-510) on the binding of sigma ligands such as [H-3](+)-3-(3-hydroxyphenyl)-N-(l-propyl)piperidine ([H-3](+)-3-PPP) and [H-3]1,3-di-o-tolylguanidine ([H-3]DTG) to rat brain membranes was studied. The inhibitory effect of FH-510 on [H-3]( + )-3-PPP binding to membranes of rat brain was 260 times more potent than that on [H-3]DTG binding. Scatchard plot analysis showed that FH-510 inhibited [H-3](+)-3-PPP binding in a competitive manner, while the inhibitory effect of FH-510 on [H-3]DTG binding was noncompetitive. These results suggest that (+)-3-PPP sites could be discriminated from DTG sites, and that FH-510 binds preferentially to ( + )-3-PPP recognition sites in rat brain.
引用
收藏
页码:173 / 175
页数:3
相关论文
共 12 条
[1]  
KARBON EW, 1991, EUR J PHARMACOL, V193, P21
[2]   SOLUBILIZATION AND CHARACTERIZATION OF SIGMA-RECEPTORS FROM GUINEA-PIG BRAIN MEMBRANES [J].
KAVANAUGH, MP ;
PARKER, J ;
BOBKER, DH ;
KEANA, JFW ;
WEBER, E .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (05) :1575-1580
[3]   IDENTIFICATION OF THE BINDING SUBUNIT OF THE DELTA-TYPE OPIATE RECEPTOR BY PHOTOAFFINITY-LABELING WITH 1-(4-AZIDO-2-METHYL[6-H-3]PHENYL)-3-(2-METHYL[4,6-H-3]PHENYL)GUANIDINE [J].
KAVANAUGH, MP ;
TESTER, BC ;
SCHERZ, MW ;
KEANA, JFW ;
WEBER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2844-2848
[4]   PSYCHOTOMIMETIC OPIATE RECEPTORS LABELED AND VISUALIZED WITH (+)-[H-3]3-(3-HYDROXYPHENYL)-N-(1-PROPYL)PIPERIDINE [J].
LARGENT, BL ;
GUNDLACH, AL ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (15) :4983-4987
[5]  
MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517
[6]  
MUSACCHIO JM, 1988, J PHARMACOL EXP THER, V247, P424
[7]  
MUSACCHIO JM, 1988, MOL PHARMACOL, V35, P1
[8]   CLASSIFICATION AND NOMENCLATURE OF PHENCYCLIDINE AND SIGMA RECEPTOR-SITES [J].
QUIRION, R ;
CHICHEPORTICHE, R ;
CONTRERAS, PC ;
JOHNSON, KM ;
LODGE, D ;
TAM, SW ;
WOODS, JH ;
ZUKIN, SR .
TRENDS IN NEUROSCIENCES, 1987, 10 (11) :444-446
[9]   A PROPOSAL FOR THE CLASSIFICATION OF SIGMA BINDING-SITES [J].
QUIRION, R ;
BOWEN, WD ;
ITZHAK, Y ;
JUNIEN, JL ;
MUSACCHIO, JM ;
ROTHMAN, RB ;
SU, TP ;
TAM, SW ;
TAYLOR, DP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (03) :85-86
[10]   NALOXONE-INACCESSIBLE SIGMA-RECEPTOR IN RAT CENTRAL NERVOUS-SYSTEM [J].
TAM, SW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (21) :6703-6707